Quarterly Results

AMAR REMEDIES LTD.

NSE : NABSE : 532664ISIN CODE : INE787G01011Industry : Household & Personal ProductsHouse : Private
BSE6.070 (0 %)
PREV CLOSE ( ) 6.07
OPEN PRICE ( ) 6.04
BID PRICE (QTY) 6.07 (32)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 139679
TODAY'S LOW / HIGH ( )5.74 6.34
52 WK LOW / HIGH ( ) 5.746.34
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Jun 2009
Audited / UnAudited
UnAudited
Net Sales
3691.64
Total Expenditure
3216.96
PBIDT (Excl OI)
474.68
Other Income
18.84
Operating Profit
493.52
Interest
124.33
Exceptional Items
NA
PBDT
369.19
Depreciation
71.21
Profit Before Tax
297.98
Tax
35
Provisions and contingencies
NA
Profit After Tax
262.98
Extraordinary Items
NA
Prior Period Expenses
NA
Other Adjustments
NA
Net Profit
262.98
Minority Interest
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
Consolidated Net Profit
262.98
Equity Capital
261.64
Face Value (IN RS)
10
Reserves
1274.39
Calculated EPS
10.05
Calculated EPS (Annualised)
40.20
No of Public Share Holdings
15000000
% of Public Share Holdings
57.33
 
NA
PBIDTM% (Excl OI)
12.85
PBIDTM%
13.36
PBDTM%
10.00
PBTM%
8.07
PATM%
7.12
 
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.